Armstrong DK - Search Results

1

The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.

Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ. Visvanathan K, et al. Among authors: armstrong dk. Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):950-5. doi: 10.1158/1055-9965.EPI-06-0974. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17507621

2

Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468.

Armstrong DK, Isaacs JT, Ottaviano YL, Davidson NE. Armstrong DK, et al. Cancer Res. 1992 Jun 15;52(12):3418-24. Cancer Res. 1992. PMID: 1534511

3

Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.

Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM, Davidson NE. Armstrong DK, et al. Cancer Res. 1992 Mar 15;52(6):1416-21. Cancer Res. 1992. PMID: 1540950

4

Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer.

Kennedy MJ, Armstrong DK, Huelskamp AM, Ohly K, Clarke BV, Colvin OM, Grochow LB, Chen TL, Davidson NE. Kennedy MJ, et al. Among authors: armstrong dk. J Clin Oncol. 1995 May;13(5):1136-43. doi: 10.1200/JCO.1995.13.5.1136. J Clin Oncol. 1995. PMID: 7738619 Clinical Trial.

5

Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells.

Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, Isaacs JT, Davidson NE. Armstrong DK, et al. Cancer Res. 1994 Oct 15;54(20):5280-3. Cancer Res. 1994. PMID: 7923154

6

Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis.

May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA, Davidson NE. May WS, et al. Among authors: armstrong dk. J Biol Chem. 1994 Oct 28;269(43):26865-70. J Biol Chem. 1994. PMID: 7929424 Free article.

7

Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer.

Armstrong DK, Fetting JH, Davidson NE, Gordon GB, Huelskamp AM, Abeloff MD. Armstrong DK, et al. Breast Cancer Res Treat. 1993 Dec;28(3):277-84. doi: 10.1007/BF00666589. Breast Cancer Res Treat. 1993. PMID: 8018956 Clinical Trial.

8

Programmed cell death in human breast cancer cells.

McCloskey DE, Armstrong DK, Jackisch C, Davidson NE. McCloskey DE, et al. Among authors: armstrong dk. Recent Prog Horm Res. 1996;51:493-508. Recent Prog Horm Res. 1996. PMID: 8701092 Review.

9

Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: a phase 2 study.

Hahm HA, Armstrong DK, Chen TL, Grochow L, Passos-Coelho J, Goodman SN, Davidson NE, Kennedy MJ. Hahm HA, et al. Among authors: armstrong dk. Biol Blood Marrow Transplant. 2000;6(3A):335-43. doi: 10.1016/s1083-8791(00)70059-0. Biol Blood Marrow Transplant. 2000. PMID: 10905771 Free article.

10

Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.

van der Wall E, Horn T, Bright E, Passos-Coehlo JL, Bond S, Clarke B, Altomonte V, McIntyre K, Vogelsang G, Noga SJ, Davis JM, Thomassen J, Ohly KV, Lee SM, Fetting J, Armstrong DK, Davidson NE, Hess AD, Kennedy MJ. van der Wall E, et al. Among authors: armstrong dk. Br J Cancer. 2000 Dec;83(11):1405-11. doi: 10.1054/bjoc.2000.1499. Br J Cancer. 2000. PMID: 11076645 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page